Related Experiment Videos
[Tracheal tumor resection and reconstruction surgery].
1First Department of Surgery, Tokai University School of Medicine, Kanagawa, Japan.
Nihon Kyobu Shikkan Gakkai Zasshi
|February 1, 1990
Summary
Surgical treatment for tracheal tumors, including adenoid cystic and thyroid carcinomas, shows promising survival rates, especially with adjuvant radiotherapy for adenoid cystic carcinoma. Early diagnosis is crucial to prevent suffocation.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Pulmonary Medicine
Background:
- Tracheal tumors are rare and can present with non-specific symptoms, often delaying diagnosis and treatment.
- Surgical resection is a primary treatment modality for both primary and secondary tracheal malignancies.
- Adenoid cystic carcinoma and thyroid carcinoma are common types of tracheal tumors requiring surgical intervention.
Observation:
- Ninety-six patients underwent surgical treatment for tracheal tumors, including tracheal resection and resection of the trachea plus carina.
- Tracheal resection was performed in 79 patients, with primary tracheal tumors (adenoid cystic carcinoma) and secondary tumors (thyroid carcinoma) being most common.
- Trachea plus carina resection was performed in 16 patients for primary pulmonary carcinomas and other tumors.
Findings:
- Eleven of 13 patients with adenoid cystic carcinoma survived without recurrence 2-9 years post-surgery; radiotherapy showed efficacy in preventing local recurrence.
- Two patients with adenoid cystic carcinoma died from recurrence 5 and 6 years post-operation.
- For thyroid carcinoma invading the trachea, 5-year and 10-year survival rates were 19/29 and 7/10, respectively, though long-term survival after residual disease was rare.
Implications:
- Surgical management of tracheal tumors, particularly adenoid cystic carcinoma, can achieve favorable long-term outcomes with appropriate adjuvant therapies.
- Timely surgical intervention is critical for improving survival in patients with tracheal malignancies, as delayed diagnosis can lead to critical airway compromise.
- Further research into optimizing treatment strategies for advanced or recurrent tracheal tumors, especially those secondary to thyroid carcinoma, is warranted.